Fundraising expertise SJA specializes in capital raising for life sciences, including private placements, Reg CF/B, Reg A+, 506 exemptions, non-dilutive funding (NIH, SBIR, CPRIT), and M&A/exit strategies, presenting multiple cross-sell opportunities for investment banking services to biotech startups and growth-stage companies.

Strategic partnerships Their consulting practice focuses on business development, licensing, and partnerships with major biopharma players, enabling opportunities to pitch alliance negotiations, collaboration frameworks, and licensing deals to potential clients seeking strategic growth.

Investor network SJA maintains a broad investor network including accredited retail investors, angels, family offices, and venture capital, offering outreach and capital-raise services that can be leveraged to accelerate client funding rounds and liquidity events.

Market visibility With a tech stack centered on HubSpot, content and analytics tools, and a presence on Squarespace and WordPress, SJA appears well-positioned to scale marketing services, lead generation, and content-driven campaigns for biotech clients.

Revenue growth Reported revenue in the low to mid single digits suggests a growth-ready target client base in early to mid-stage biotech and medtech firms seeking fundraising, strategic partnerships, and M&A advisory to unlock shareholder value.